Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 10.00
0.00 (0.00%)
At close: Feb 9, 2026
Devonian Health Group Market Cap
Devonian Health Group has a market cap or net worth of CAD 27.66 million as of February 9, 2026. Its market cap has decreased by -23.42% in one year.
Market Cap
27.66M
Enterprise Value
21.13M
Revenue
18.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.00
Market Cap Chart
Since May 19, 2017, Devonian Health Group's market cap has decreased from 1.44B to 27.66M, a decrease of -98.08%. That is a compound annual growth rate of -36.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 27.66M | -12.28% |
| Dec 24, 2025 | 31.53M | 32.95% |
| Dec 30, 2024 | 23.72M | 11.47% |
| Dec 21, 2023 | 21.28M | -52.33% |
| Dec 21, 2022 | 44.63M | -94.11% |
| Dec 31, 2021 | 758.36M | 359.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedMira | 45.61M |
| BriaCell Therapeutics | 35.59M |
| Defence Therapeutics | 33.85M |
| Microbix Biosystems | 33.31M |
| Thiogenesis Therapeutics | 31.10M |
| Resverlogix | 30.21M |
| Telescope Innovations | 29.49M |
| Quantum BioPharma | 20.13M |